Viveve Medical, Inc. (NASDAQ:VIVE – Get Rating) saw a significant increase in short interest in the month of November. As of November 30th, there was short interest totalling 178,100 shares, an increase of 98.8% from the November 15th total of 89,600 shares. Based on an average trading volume of 22,900 shares, the short-interest ratio is presently 7.8 days.
Viveve Medical Price Performance
Shares of VIVE stock opened at $0.38 on Wednesday. The business has a 50 day moving average of $0.51 and a two-hundred day moving average of $0.67. Viveve Medical has a 52 week low of $0.36 and a 52 week high of $1.50. The company has a market cap of $4.10 million, a P/E ratio of -0.14 and a beta of 0.41.
Get Viveve Medical alerts:About Viveve Medical
(Get Rating)
Viveve Medical, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components.Further Reading
- Get a free copy of the StockNews.com research report on Viveve Medical (VIVE)
- REV Group Leads Specialty Vehicle Manufacturers Higher
- NVIDIA vs AMD: Which is better for 2023?
- We Are the Champions: 3 Dividend Growers Wall Street Loves
- Will Nordstrom Stock be the Grinch This Year?
- Harpoon Therapeutics Remains Volatile After Promising News
Receive News & Ratings for Viveve Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical and related companies with MarketBeat.com's FREE daily email newsletter.